The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
GoodRx Holdings Inc's Score
Industry at a Glance
Industry Ranking
95 / 484
Overall Ranking
176 / 4593
Industry
Software & IT Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
15
analysts
Buy
Current Rating
5.089
Target Price
+94.25%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
GoodRx Holdings Inc Highlights
StrengthsRisks
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 31.22, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 65.92M shares, decreasing 30.03% quarter-over-quarter.
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.
Ticker SymbolGDRX
CompanyGoodRx Holdings Inc
CEOMs. Wendy Lynn Barnes
Websitehttps://investors.goodrx.com/
FAQs
What is the current price of GoodRx Holdings Inc (GDRX)?
The current price of GoodRx Holdings Inc (GDRX) is 2.710.
What is the symbol of GoodRx Holdings Inc?
The ticker symbol of GoodRx Holdings Inc is GDRX.
What is the 52-week high of GoodRx Holdings Inc?
The 52-week high of GoodRx Holdings Inc is 5.810.
What is the 52-week low of GoodRx Holdings Inc?
The 52-week low of GoodRx Holdings Inc is 2.660.
What is the market capitalization of GoodRx Holdings Inc?
The market capitalization of GoodRx Holdings Inc is 924.58M.
What is the net income of GoodRx Holdings Inc?
The net income of GoodRx Holdings Inc is 16.39M.
Is GoodRx Holdings Inc (GDRX) currently rated as Buy, Hold, or Sell?
According to analysts, GoodRx Holdings Inc (GDRX) has an overall rating of Buy, with a price target of 5.089.
What is the Earnings Per Share (EPS TTM) of GoodRx Holdings Inc (GDRX)?
The Earnings Per Share (EPS TTM) of GoodRx Holdings Inc (GDRX) is 0.087.